Literature DB >> 18827428

Reversible respiratory failure due to rhabdomyolysis associated with cytomegalovirus infection.

Daigoro Hirohama1, Toshio Shimizu, Kazuki Hashimura, Mina Yamaguchi, Mikio Takamori, Yumi Awatsu, Motoyoshi Tsujino, Toshio Mizutani.   

Abstract

A 58-year-old woman presented with muscle weakness, whole body myalgia, and dyspnea. On admission, neurological examination showed proximal muscle weakness in the extremities. The weakness gradually extended to the bulbar and respiratory muscles, necessitating an artificial ventilator. Serum CK level was markedly increased (33,774 IU/L; normal <150 IU/L) and myoglobinuria was noted in urinalysis. There was no sign of renal failure. Nerve conduction study was normal, but needle EMG showed myopathic changes in the weak muscles. Serological studies for virus titers showed more than a four-fold increase of cytomegalovirus (CMV) antibody titer during the disease course. The IgM anti-GM2 antibody was also elevated in the acute phase and decreased in the recovery phase. The muscle weakness and respiratory failure gradually improved after intravenous methylprednisolone administration, and the serum CK level was normalized in several days. CMV infection was thought to have played a central role in the rhabdomyolysis, leading to critical but reversible respiratory muscle paralysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18827428     DOI: 10.2169/internalmedicine.47.1349

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  Illegal immigration: the puzzling role of several risk factors for rhabdomyolysis.

Authors:  Laura Colavita; Valeria Dipasquale; Giovanni Stroscio; Carmelo Salpietro
Journal:  BMJ Case Rep       Date:  2018-01-23

2.  Severe rhabdomyolysis associated with a primary cytomegalovirus infection in an immunocompetent patient.

Authors:  Héloïse Gindre; Léonard Féasson; Christian Auboyer; Pascal Cathébras
Journal:  BMJ Case Rep       Date:  2013-02-13

3.  Corticosteroids in the treatment of alcohol-induced rhabdomyolysis.

Authors:  James W Antoon; Chayan Chakraborti
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

4.  Peculiar histological and ultrastructural skeletal muscle alterations in a patient with CMV infection and autoimmune myositis: case evaluation and brief literature review.

Authors:  Michela Ripolone; Laura Napoli; Vittorio Mantero; Monica Sciacco; Simona Zanotti
Journal:  Acta Myol       Date:  2022-03-31

5.  A case of corticosteroid-responsive SARS-CoV-2 related massive rhabdomyolysis.

Authors:  Maria Cunha; Inês Pinho; Marta Lopes; Frederico Trigueiros; Sandra Braz; Fábio Medeiros
Journal:  IDCases       Date:  2020-09-04

6.  Short-Term High-Dose Steroid Therapy in a Case of Rhabdomyolysis Refractory to Intravenous Fluids.

Authors:  Fnu Zarlasht; Mashal Salehi; Alamgir Sattar; Mohammad Abu-Hishmeh; Muzammil Khan
Journal:  Am J Case Rep       Date:  2017-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.